Mood disorders rank fourth among the most significant global public health problems. 1 The prevalence of the juvenile-onset subtype of depressive disorder increases dramatically across the years of childhood and adolescence, with an estimated lifetime prevalence close to 20% by late adolescence. 2 Juvenile-onset mood disorders are associated with serious morbidity, including recurrence, impaired interpersonal functioning, and increased risks of bipolar disorder and suicide. 2, 3 The influence of hereditary factors on susceptibility to major depression has been documented based on twin and adoption studies. 4 Twin studies in youth have identified significant heritability for depressive symptoms. 5, 6 It has also been proposed that genetic aspects of liability to mood disorder may be more readily identified in families of childhood-and adolescentonset probands. 7 Accordingly, first-degree relatives of childhood-onset mood disorder probands have higher rates of affective disorder than do first-degree relatives of adult-onset mood disorder probands. 8 Evidence from both preclinical and clinical studies implicates brain-derived neurotrophic factor (BDNF) in mood disorders. Altered BDNF expression in stress-related depression via cellular signalling has been described in animal models. Repeated antidepressant administration, including electroconvulsive seizures, is associated with increased hippocampal BDNF expression, neuronal plasticity and neurogenesis. [9] [10] [11] Human neuroimaging 12, 13 post mortem 14 and clinical [15] [16] [17] investigations indirectly support the hypothesis that neurotrophic factors play a key role in depression. As well, human linkage studies in bipolar disorder suggest that the 11p13-14 region could harbor polymorphisms affecting susceptibility to mood disorders. 18, 19 The BDNF gene is located in this region, making it not only a functional, but a positional candidate risk locus for mood disorders.
Previous human candidate gene investigations show association between BDNF markers and hippocampal dysfunction and mood disorders. Functional genetic studies demonstrate that the Val 66 Met SNP met allele is associated with reduced hippocampal synaptic activity 20 and diminished hippocampal and prefrontal cortical volumes. 21 These findings are of note because regions of the hippocampus and prefrontal cortices support functions increasingly implicated in mood disorders. Two studies of mood disorders in adults have indicated that BDNF variants are associated with bipolar disorder: according to one association study of 283 trios, 22 the 170 bp allele of the (GT) n marker and the val allele of the Val 66 Met were related to vulnerability; a larger study involving 470 trios from three samples showed significant overtransmission of the Val
66
Met val allele to probands in one sample and trends towards overtransmission in two other samples. 23 As is common in association studies of complex disorders, there also are several nonreplications. [24] [25] [26] [27] [28] [29] Further evidence implicating the BDNF locus' involvement in mood disorders arises from studies of neuroticism, a trait highly correlated with depression. [30] [31] [32] [33] We have recently described an association between the BDNF (GT) n marker and a haplotype containing the Val 66 Met val allele with COMD in 93 case-control pairs. 34 Overall, substantial reason exists to further examine BDNF as a candidate gene for depressive disorders such as COMD.
The aim of the current research was to crossvalidate our previous findings by testing for association between BDNF markers and COMD in a new and larger sample of families having a child proband with COMD. We evaluated five SNPs for single marker associations, and did an evolutionary-based haplotype analysis using tag SNPs selected by clustering methods. This genetic investigation occurs in the setting of a larger multidisciplinary research program on risk factors for and correlates of COMD, whose overarching theme concerns the characteristics, development and role of emotion regulatory strategies in very early-onset mood disorder.
Methods

Participants
The sample consisted of 258 small families recruited from 21 child psychiatric and mental health facilities across Hungary, in which the target child proband met DSM-IV criteria for mood disorder (major depressive, dysthymic, or bipolar I or II disorder) with first onset by age 14.99. Proband gender was 47.7% female. Probands were free from mental retardation or major systemic medical illness. Caseness required two evaluations by different trained interviewers, approximately 1 month apart (including at each occasion separate interviews with the parent about the child, and the child about him/herself), and independent verification by consensus best-estimate diagnosis. The standardized Interview Schedule for Children and Adolescents-Diagnostic Version (ISCA-D), an extension of the semistructured ISCA, 35 was used to determine diagnosis. Experimental methods met with IRB approval at the University of Pittsburgh, the Centre for Addiction and Mental Health, and the various recruitment sites in Hungary. Written informed consents were obtained from the parent(s) and child.
Laboratory DNA was extracted from lymphocytes using a high salt method, 36 and in some cases from buccal swabs using NaOH and Proteinase K (QIAmp DNA Mini Kit, Qiagen Inc.). The intron-exon structure and splicing of the gene are complex and are beginning to be understood better. 37 The functional BDNF Val 66 Met SNP (Egan et al; 20 NCBI SNP ID rs6265) was typed using primers, probes and PCR conditions developed by Applied Biosystems Inc. (ABI Assay ID C__11592758_10). Amplification and detection of the PCR products were performed with an ABI Prism s 7000 sequence detection instrument (Applied Biosystems Inc., Foster City, CA, USA), as suggested by the manufacturer, by use of all default program settings. The PCR products were detected as an increase in reporter dye fluorescence during the PCR extension phase when the probes were cleaved by the 5 0 exonuclease activity of the Taq DNA polymerase. Genotypes were resolved based on the distribution of fluorescence on an X-Y scatter plot. Four other SNPs we named BDNF1 (Celera ID hCV11592756), BDNF2 (Celera ID hCV1751792), BDNF3
(NCBI ID rs2049045, Celera ID hCV12035465) and BDNF4 (Celera ID hCV1751796) BDNF1  C__11592756_10  rs4923463  hCV11592756  Intron  Val66Met  C__11592758_10  rs6265  hCV11592758  Missense mutation  BDNF2  C__1751792_10  rs11030104  hCV1751792  Intron  BDNF3  C__12035465_10  rs2049045  hCV12035465  Intron  BDNF4  C__1751796_10  rs7103411  hCV1751796  Intergenic/unknown were assayed using similar methods (see Table 1 ). 41 were used to analyze the (GT) n variant for association with affection status and LD, respectively. Hierarchical cluster analysis was used to select tag SNPs, as implemented in Hclust. 42 Haplotype-based association analyses were performed with the program eHap. 43 
Results
All five SNPs were in Hardy-Weinberg equilibrium (0.393oPo0.925). For the (GT) n microsatellite, observed homozygosity did not differ from expected homozygosity in the entire sample
The (GT) n microsatellite had three common alleles (allele 4 ¼ 168 bp, allele 3 ¼ 170 bp and allele 1 ¼ 174 bp). FBAT results were suggestive of association for two of the three common (GT) n alleles: 170 bp (Z ¼ 2.095, P ¼ 0.036) and 174 bp (Z ¼ À2.058, P ¼ 0.04). See Table 2 .
Single SNP association results indicated biased transmission of the more common allele for each of the five SNPs: BDNF1 (A allele overtransmitted; Table 3 No differences in transmission rates were observed when the data were reanalyzed according to proband sex-overtransmission of common alleles occurred to both sexes.
Two tag SNPs adequately covered the set of correlated SNPs, Val 66 Met and BDNF2. For these SNPs, maximum likelihood estimation indicates that all four possible haplotypes exist in our sample (Figure 2 ). By necessity, these haplotypes form a network of single-step mutations. To deduce a cladistic relationship (Figure 2 ) among the haplotypes from the network (ie break at least one edge), the program eHap used a set of algorithms based on simple evolutionary principles. 44 The program eHap then uses this cladistic structure to test for equality of haplotypes transmissions of haplotypes connected by an edge. Transmission rates for haplotypes 1 and 3 ( Figure 2 ) were found to be indistinguishable; the same was true for haplotypes 2 and 4. Therefore, haplotypes 1 and 3 were forced to have equal transmission rates, as were 2 and 4; then the transmission rates for these pairs were contrasted. In this case, haplotypes 1/3 had significantly different rates of transmission than 2/4 (score test P ¼ 0.0029). The difference was driven by the contrast between the two most common haplotypes: 1 (met-G) and 4 (val-A).
We did not re-evaluate the Val 66 Met-(GT) n twomarker haplotype transmission analysis completed in the Pittsburgh sample. 34 In that haplotype analysis, (GT) n alleles were classified as long (Z170 bp) or short (o170 bp). Such an analysis in the Hungarian sample would have involved combining the 170 and 174 bp as long (Z170 bp) alleles; however the transmission biases were in opposite directions for these two most common (GT) n alleles. Thus, the current (GT) n single marker analysis suggested we should not perform a Val 66 Met-(GT) n two-marker haplotype transmission test analogous to that performed in the original Pittsburgh sample.
Discussion
Genetic variation in BDNF has recently been found to be associated with juvenile-onset depression 34 and child bipolar disorder, 45 as well as adult-ascertained samples of bipolar disorder and neuroticism (see Introduction). To further evaluate the association of variation in BDNF with COMD, we genotyped six polymorphisms in a relatively large family-based sample from Hungary. We found a positive trend with the microsatellite and significant association between all five SNPs genotyped within BDNF. Evolutionary haplotype analysis of two tag SNPsVal 66 Met and BDNF2-identified the val-A as the risk haplotype.
Some caveats must be borne in mind when judging these results. Sample size would ideally be larger, although this is the largest study of COMD reported to date. Another drawback was that we were not able to test for association with bipolar disorder since too few probands had experienced a hypomanic or manic episode at the time of this analysis to yield meaningful findings. In the future, as the sample matures, we may be able to examine a juvenile bipolar phenotype.
Our analyses of the LD structure of the five SNPs show that pairwise LD for all five 'choose two' pairs is high, and tag SNP selection shows that only two of the five are actually needed to represent the entire set-Val 66 Met and BDNF2. Therefore, the only 'penalty' required for multiple testing the five SNPs as independent would be 0.05/2 ¼ 0.025. Including the (GT) n variant, it would be 0.05/3E0.017, assuming the (GT) n alleles are independent of the SNP alleles, which is not so. Under either correction, transmission of BDNF SNP alleles is significantly associated with COMD. The LD among the polymorphisms makes it difficult to distinguish which polymorphism is more likely to have a causal impact. The functional significance of Val 66 Met makes it particularly noteworthy; however, the (GT) n marker could contribute to risk by a different mechanism (eg mRNA stability could change with different alleles of a dinucleotide repeat). While the Val 66 Met is more interesting because of the functional studies, it is curious that the val allele tends to be associated with mood disorders while the evidence for memory and hippocampal dysfunction lies with the met allele. 20, 21, 46 Relative statistical significance does not help to differentiate which is the most likely causal alleleanalyses reported in Seltman et al 43, 47 and Roeder et al 48 show that significance levels are poor predictors of biological effects within genes; in those reports, even though a single variant affected liability, the signal for association often was more powerful for other variants.
Two published reports have considered BDNF polymorphisms and juvenile onset mood disorder phenotypes. 34, 45 In both reports, the sample sizes were smaller than the current one-53 trios in the St Louis study and 99 case-control pairs in our Pittsburghbased study. The St Louis study considered prepubertal and early adolescent bipolar disorder (PEA-BP), while our Pittsburgh study considered bipolar and unipolar probands together because there were too few bipolar probands for a separate analysis. While Geller et al 45 noted biased transmission of the valine allele, testing no other variants, our previous study in the Pittsburgh sample did not find Val 66 Met significant by allelic or genotypic analysis, but rather the 168 bp allele of the (GT) n repeat was significant. However, our haplotype analysis indicated that the val-short (o170 bp) haplotype containing the Val 66-Met valine allele was associated with COMD. The dissimilar risk alleles across studies could reflect the different ancestry of the samples, and/or the contrasting designs of case-control vs the family-based transmission strategies. While the current haplotype analyses from Hungarian data do not exactly replicate the val-short association from the Pittsburgh casecontrol study, they do strongly suggest the relevance of another common haplotype containing the Val 66-Met valine allele. Smaller samples, case-control designs and ethnic heterogeneity are more likely to produce false positive results.
Previous genetic association studies of BDNF and mood disorders have focused mainly on bipolar disorder and neuroticism in adults and have yielded mixed results. It is quite possible that nonreplications are due to ethnicity-dependent effects or clinical heterogeneity. The principal difference between these investigations and ours is that we have focused on the phenotype of juvenile-onset depressive disorders, thereby reducing phenotypic heterogeneity inherent in mood disorders due to age-of-onset. All three candidate gene studies of BDNF in mood disorders with juvenile onset to date have been positive. 34, 45 A common theme across multiple investigations in a variety of phenotypes (excluding declarative episodic memory) suggests that when BDNF variants are associated with risk for illness, it is most often the common alleles and haplotypes that are associated with psychopathology. Hall et al 49 found the most common haplotype (C-T-val-C, P ¼ 0.007) to be associated with risk for OCD and a less common mirror haplotype (G-A-met-G, P ¼ 0.002) to be associated with protection from it. Similarly, Neves-Pereira et al 22 noted the common alleles and common haplotype (3-val, P ¼ 0.0039) to be overtransmitted and the mirror haplotype to be relatively undertransmitted (1-met, P ¼ 0.013) in bipolar disorder. In Sklar et al's 23 Hopkins sample, the most common val-containing haplotype was associated with BP (P ¼ 0.00096), while the low frequency met-containing haplotype reduced hazard (P ¼ 0.030). While for schizophrenia, the common val-3 haplotype was not associated with phenotype, the next most frequent haplotype was associated with risk (val-1, Bonferroni-corrected P ¼ 0.04) while the less common met-1 haplotype conferred reduced risk (Bonferroni-corrected P ¼ 4.65 Â 10
À7
). 27 The various phenotypes associated with the BDNF gene may share in common some aspect of their respective psychopathologic processes.
We find common Val
66
Met val-containing haplotypes to be associated with risk in both Pittsburgh (val-short, P ¼ 0.0003) 34 and in the current sample. Based on the similarities in BDNF alleles and haplotypes showing association across a variety of psychopathologies, a common disease-common variant/common haplotype hypothesis might apply to several phenotypes exhibiting association with the BDNF locus. Overall, the current study provides further evidence that BDNF variants are associated with risk for COMD, lending support to a rationale involving neuroplasticity and neurogenesis in the development of mood disorders.
